These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1092372)

  • 1. Mode of action of the cloacin DF13-immunity protein.
    Oudega B; Klaasen-Boor P; De Graaf FK
    Biochim Biophys Acta; 1975 May; 392(1):184-95. PubMed ID: 1092372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF16: action of the immunity protein in vivo and in vitro.
    Kool AJ; Borstlap AJ; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):76-85. PubMed ID: 1099984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF13: purification and characterization of the immunity protein.
    Kool AJ; Pols C; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):67-75. PubMed ID: 1099983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular structure of the immunity gene and immunity protein of the bacteriocinogenic plasmid Clo DF13.
    van den Elzen PJ; Gaastra W; Spelt CE; de Graaf FK; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1980 Oct; 8(19):4349-63. PubMed ID: 6253914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of temperature on the activity of cloacin DF13 and cloacin DF13-immunity protein.
    Oudega B; Meekel CJ; De Graaf FK
    Biochim Biophys Acta; 1975 Jul; 399(1):213-6. PubMed ID: 1148276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a complex between cloacin and its immunity protein isolated from Enterobacter cloacae (Clo DF13). Dissociation and reconstitution of the complex.
    De Graaf FK; Klaasen-Boor P
    Eur J Biochem; 1977 Feb; 73(1):107-14. PubMed ID: 402267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13.
    Akutsu A; Masaki H; Ohta T
    J Bacteriol; 1989 Dec; 171(12):6430-6. PubMed ID: 2687234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of colicin E2, colicin E3 and cloacin DF13.
    De Graaf FK
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):121-34. PubMed ID: 506538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of divalent cations and of phospholipase A activity on excretion of cloacin DF13 and lysis of host cells.
    Luirink J; van der Sande C; Tommassen J; Veltkamp E; De Graaf FK; Oudega B
    J Gen Microbiol; 1986 Mar; 132(3):825-34. PubMed ID: 3016150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of cloacin DF13 receptor from Enterobacter cloacae and its interaction with cloacin DF13 in vitro.
    Oudega B; Oldenziel-Werner WJ; Klaasen-Boor P; Rezee A; Glas J; de Graaf FK
    J Bacteriol; 1979 Apr; 138(1):7-16. PubMed ID: 35522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of cloacin DF13 by susceptible cells: removal of immunity protein and fragmentation of cloacin molecules.
    Krone WJ; de Vries P; Koningstein G; de Jonge AJ; de Graaf FK; Oudega B
    J Bacteriol; 1986 Apr; 166(1):260-8. PubMed ID: 2420782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clo DF13 plasmid deoxyribonucleic acid-directed in vitro synthesis of biologically active cloacin DF13 and clo DF13 immunity protein.
    Konings RN; Andreoli PM; Veltkamp E; Nijkamp HJ
    J Bacteriol; 1976 May; 126(2):861-8. PubMed ID: 770456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of the Clo DF13 plasmid in Escherichia coli with a decreased bacteriocinogenic activity.
    Andreoli PM; Nijkamp HJ
    Mol Gen Genet; 1976 Mar; 144(2):159-70. PubMed ID: 775289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic properties of cloacin DF13 and kinetics of ribosome inactivation.
    Oudega B; de Graaf FK
    Biochim Biophys Acta; 1976 Mar; 425(3):296-304. PubMed ID: 4102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the cloacin DF13 immunity protein.
    de Graaf FK; Klaasen-Boor P
    FEBS Lett; 1974 Apr; 40(2):293-6. PubMed ID: 4604994
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of messenger ribonucleic acids and proteins synthesized by the bacteriocinogenic factor Clo DF13 in purified minicells of Escherichia coli.
    Kool AJ; van Zeben MS; Nijkamp HJ
    J Bacteriol; 1974 Apr; 118(1):213-24. PubMed ID: 4595198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-determined cloacin DF13-susceptibility in Enterobacter cloacae and Klebsiella edwardsii; identification of the cloacin DF13/aerobactin outer membrane receptor proteins.
    Krone WJ; Koningstein G; de Graaf FK; Oudega B
    Antonie Van Leeuwenhoek; 1985; 51(2):203-18. PubMed ID: 4037784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three immunity types of klebicins which use the cloacin DF13 receptor of Klebsiella pneumoniae.
    Cooper PC; James R
    J Gen Microbiol; 1985 Sep; 131(9):2313-8. PubMed ID: 3906039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of Escherichia coli to cloacin DF13 involves the major outer membrane protein OmpF.
    Wooldridge KG; Williams PH
    J Bacteriol; 1991 Apr; 173(8):2420-4. PubMed ID: 2013565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and excretion of cloacin DF13 by Escherichia coli harboring plasmid CloDF13.
    Van Tiel-Menkvled GJ; Rezee A; De Graaf FK
    J Bacteriol; 1979 Nov; 140(2):415-23. PubMed ID: 227839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.